Generic name: DEXMETHYLPHENIDATE HYDROCHLORIDE 2.5mg
Dosage form: tablet
Medically reviewed by Drugs.com. Last updated on Jan 31, 2019.
2.1 Pretreatment Screening
Prior to treating pediatric patients and adults with central nervous system (CNS) stimulants, including Focalin, assess for the presence of cardiac disease (i.e., perform a careful history, family history of sudden death or ventricular arrhythmia, and physical exam) [see Warnings and Precautions 5.2].
Assess the risk of abuse prior to prescribing, and monitor for signs of abuse and dependence while on therapy. Maintain careful prescription records, educate patients about abuse, monitor for signs of abuse and overdose, and periodically reevaluate the need for Focalin use [see Boxed Warning, Warnings and Precautions (5.1), Drug Abuse and Dependence (9)].
2.2 Pediatric Patients with ADHD
Patients New to Methylphenidate
The recommended starting dose of Focalin for pediatric patients who are not currently taking racemic methylphenidate, or for patients who are on stimulants other than methylphenidate, is 5 mg daily (2.5 mg twice daily) with or without food.
Patients Currently on Methylphenidate
The recommended starting dose of Focalin for pediatric patients currently using methylphenidate is half the total daily dose of racemic methylphenidate.
The dose may be titrated weekly in increments of 2.5 to 5 mg to a maximum of 20 mg daily (10 mg twice daily). The dose should be individualized according to the needs and response of the patient.
Pharmacological treatment of ADHD may be needed for extended periods. Periodically reevaluate the long-term use of Focalin and adjust dosage as needed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Focalin (dexmethylphenidate)
- Side Effects
- During Pregnancy or Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 68 Reviews
- Generic Availability
- Drug class: CNS stimulants
- FDA Alerts (1)